ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
34
views
0
references
Top references
cited by
187
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,781
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
Author(s):
David R.W. Jayne
,
Annette N. Bruchfeld
,
Lorraine Harper
,
Matthias Schaier
,
Michael C. Venning
,
Patrick Hamilton
,
Volker Burst
,
Franziska Grundmann
,
Michel Jadoul
,
István Szombati
,
Vladimír Tesař
,
Mårten Segelmark
,
Antonia Potarca
,
Thomas J. Schall
,
Pirow Bekker
1
Publication date
(Print):
April 2017
Journal:
Journal of the American Society of Nephrology
Publisher:
American Society of Nephrology (ASN)
Read this article at
ScienceOpen
Publisher
PMC
Further versions
open (via free pdf)
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
oa repository (via OAI-PMH doi match)
oa repository (via OAI-PMH doi match)
oa repository (via OAI-PMH title and first author match)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Related collections
Herbal Medicines Journal (Herb Med J)
Author and article information
Journal
Title:
Journal of the American Society of Nephrology
Abbreviated Title:
JASN
Publisher:
American Society of Nephrology (ASN)
ISSN (Print):
1046-6673
ISSN (Electronic):
1533-3450
Publication date (Print):
April 2017
Volume
:
Issue
:
Page
: ASN.2016111179
Affiliations
[
1
]
for the CLEAR Study Group
Article
DOI:
10.1681/ASN.2016111179
PMC ID:
5576933
PubMed ID:
28400446
SO-VID:
28ed9289-9a40-4746-a741-398fd1e1164d
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,781
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis
Authors:
Masayoshi Harigai
,
Hideto Takada
C5A Receptor Inhibitor Avacopan in IgA Nephropathy Study
Authors:
A. BRUCHFELD
,
P Nachman
,
S Parikh
…
Identifier NCT03301467, controlled trial evaluating avacopan in C3 glomerulopathy (ACCOLADE)
Authors:
See all similar
Cited by
182
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
Authors:
Julien Carvelli
,
Olivier Demaria
,
Frédéric Vély
…
Neutrophils as emerging therapeutic targets
Authors:
Tamas Nemeth
,
Markus Sperandio
,
Attila Mócsai
ANCA-associated vasculitis
Authors:
A. Kitching
,
Hans-Joachim Anders
,
Neil Basu
…
See all cited by
Version 1
- Current
Version 1